EU Calls For COVID-19 Diagnostic Research Projects
The Innovative Medicines Initiative is offering €45m in funding
As fears grow that a full-blown COVID-19 pandemic may be on the way, a European public-private consortium is to make available a total of €45m (US$49m) in funding for projects aimed at accelerating the development of diagnostics and therapeutics to help tackle the current outbreak and any future coronavirus threats.
You may also be interested in...
With the rapid global spread of the coronavirus, Medtech Insight looks at the predicted economic impact of the outbreak on the industry’s biggest businesses.
The value of rare disease research must not be overlooked as the drive to diagnose and contain coronavirus mounts.
With cases of novel coronavirus infection rising at an alarming rate, the industry in Europe is being urged to contribute what it can by way of new products for detecting, diagnosing or treating the disease. Several research projects are also being run or started up with EU funding.